NO157143C - Fremgangsmaate for fremstilling av karbapen-2-em-derivater. - Google Patents

Fremgangsmaate for fremstilling av karbapen-2-em-derivater.

Info

Publication number
NO157143C
NO157143C NO811628A NO811628A NO157143C NO 157143 C NO157143 C NO 157143C NO 811628 A NO811628 A NO 811628A NO 811628 A NO811628 A NO 811628A NO 157143 C NO157143 C NO 157143C
Authority
NO
Norway
Prior art keywords
carbapen
derivatives
procedure
preparation
Prior art date
Application number
NO811628A
Other languages
English (en)
Other versions
NO811628L (no
NO157143B (no
Inventor
Robert Louis Rosati
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO811628L publication Critical patent/NO811628L/no
Publication of NO157143B publication Critical patent/NO157143B/no
Publication of NO157143C publication Critical patent/NO157143C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/26Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO811628A 1980-05-14 1981-05-13 Fremgangsmaate for fremstilling av karbapen-2-em-derivater. NO157143C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14960480A 1980-05-14 1980-05-14
US06/232,156 US4348264A (en) 1980-05-14 1981-02-09 Photocatalyzed process for producing carbapenams and carbapen-2-ems

Publications (3)

Publication Number Publication Date
NO811628L NO811628L (no) 1981-11-16
NO157143B NO157143B (no) 1987-10-19
NO157143C true NO157143C (no) 1988-01-27

Family

ID=26846880

Family Applications (1)

Application Number Title Priority Date Filing Date
NO811628A NO157143C (no) 1980-05-14 1981-05-13 Fremgangsmaate for fremstilling av karbapen-2-em-derivater.

Country Status (17)

Country Link
US (1) US4348264A (no)
EP (1) EP0040494B1 (no)
KR (1) KR840000722B1 (no)
AR (1) AR227425A1 (no)
AU (1) AU524882B2 (no)
CA (1) CA1171415A (no)
DE (1) DE3162245D1 (no)
DK (1) DK169892B1 (no)
ES (1) ES8203373A1 (no)
FI (1) FI72518C (no)
IE (1) IE51268B1 (no)
IL (1) IL62848A (no)
NO (1) NO157143C (no)
NZ (1) NZ197072A (no)
PH (1) PH16363A (no)
PT (1) PT73026B (no)
YU (1) YU43031B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4429128A (en) 1981-02-09 1984-01-31 Pfizer Inc. Carbapenams and carbapen-2-ems and process therefor
EP0160876A1 (en) * 1984-04-23 1985-11-13 Merck & Co. Inc. 1-Hetero-6-/1-Hydroxyethyl/-2-SR8-1-carbadethiapen-2-EM-3-carboxylic acids
DK270685A (da) * 1984-06-29 1985-12-30 Hoffmann La Roche Carbapenemderivater
US4675186A (en) 1985-04-18 1987-06-23 Pfizer Inc. 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives
US5395931A (en) * 1988-06-30 1995-03-07 Merck & Co., Inc. 6-amido-1-methyl-2-(substituted-thio)carbapenems
US5138050A (en) * 1988-06-30 1992-08-11 Merck & Co., Inc. 6-amido-1-methyl carbapenems
US5055463A (en) * 1989-02-02 1991-10-08 Merck & Co., Inc. Spirocyclic 6-amido carbapenems
EP1263762A4 (en) * 2000-02-28 2003-04-02 Newbiotics Inc ANTI-INFECTIOUS ECTA

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592751A (en) * 1969-04-14 1971-07-13 Lilly Co Eli Penicillin sulfoxide conversion process
US4234596A (en) * 1976-11-19 1980-11-18 Merck & Co., Inc. 3-(2-Aminoethylthio)-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
BE867227A (fr) 1977-10-31 1978-11-20 Merck & Co Inc Preparation de l'acide 6-(alpha-hydroxyethyl)-7-oxo-1-azabicyclo (3,2,0) hept-2-ene-carboxylique et derives a activite antibiotique
US4208422A (en) * 1978-10-24 1980-06-17 Merck & Co., Inc. 1-Substituted-pen-2-em-3-carboxylic acids
US4262010A (en) * 1979-12-03 1981-04-14 Merck & Co., Inc. 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1,1-disubstituted-1-carbadethiapen-2-em-3-carboxylic acids

Also Published As

Publication number Publication date
IE811070L (en) 1981-11-14
DK211381A (da) 1981-11-15
PH16363A (en) 1983-09-08
DK169892B1 (da) 1995-03-27
DE3162245D1 (en) 1984-03-22
IE51268B1 (en) 1986-11-26
ES502204A0 (es) 1982-04-01
AU7051381A (en) 1981-11-19
CA1171415A (en) 1984-07-24
IL62848A (en) 1984-05-31
FI811471L (fi) 1981-11-15
EP0040494B1 (en) 1984-02-15
KR830006288A (ko) 1983-09-20
ES8203373A1 (es) 1982-04-01
NZ197072A (en) 1983-12-16
AR227425A1 (es) 1982-10-29
YU43031B (en) 1989-02-28
NO811628L (no) 1981-11-16
EP0040494A1 (en) 1981-11-25
FI72518C (fi) 1987-06-08
PT73026A (en) 1981-06-01
AU524882B2 (en) 1982-10-07
US4348264A (en) 1982-09-07
PT73026B (en) 1983-02-08
KR840000722B1 (ko) 1984-05-24
FI72518B (fi) 1987-02-27
IL62848A0 (en) 1981-07-31
NO157143B (no) 1987-10-19
YU122181A (en) 1983-06-30

Similar Documents

Publication Publication Date Title
NO821087L (no) Fremgangsmaate for fremstilling av cyklobutan-derivater.
NO810765L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO811731L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater
NO813678L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
NO158461C (no) Analogifremgangsmaate for fremstilling av fenyl-piperidin-propanol-derivater.
NO163668C (no) Fremgangsmaate for fremstilling av immunogent kompleks.
NO159667C (no) Fremgangsmaate for fremstilling av kikhostetoksid.
NO813208L (no) Fremgangsmaate for fremstilling av 3-aryl-5-isotiazol-derivater.
NO814065L (no) Fremgansmaate for fremstilling av imidazolylfenylamidiner
NO158136C (no) Fremgangsmaate til fremstilling av tiadiazolderivater.
NO155693C (no) Fremgangsmaate for fremstilling av eburnamoninderivater.
NO822634L (no) Fremgangsmaate for fremstilling av cefemderivater.
NO812519L (no) Fremgangsmaate for fremstilling av kolesterase.
NO812701L (no) Fremgangsmaate for fremstilling av antibakterielle timetyl-cefalosporiner.
NO813477L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
NO157143C (no) Fremgangsmaate for fremstilling av karbapen-2-em-derivater.
NO162018C (no) Fremgangsmaate for fremstilling av 4-metyl-5-alkyltiometylimidazoler.
NO157652C (no) Fremgangsmaate for fremstilling av 3-pikolin.
NO152840C (no) Fremgangsmaate for fremstilling av dibenzyletere.
NO810114L (no) Fremgangsmaate for fremstilling av kijanimicin.
NO812842L (no) Fremgangsmaate for fremstilling av aminoacetonitil-derivater
ES517428A0 (es) Procedimiento de preparacion de derivados bencilidenicos.
NO155666C (no) Fremgangsmaate for fremstilling av 5,6,7,7a-tetrahydro-4h-thieno-(3,2-c)-pyridin-2-on-derivater.
NO159268C (no) Fremgangsmaate for fremstilling av 3-pikolin.
ES504338A0 (es) Procedimiento de preparacion de derivados difeniletericos